▟ Vinebot intrinsic value, daily

← back

WFC Wells Fargo

bank · valued with opus medium conviction · deep-dived 2026-11-17

BUY
Intrinsic value$74.43
Price (at call)$84.84
Margin of safety -12.3%
vs market (rating basis) +17.3%

Asset cap gone, returns near 13.5% through the cycle; at roughly 1.55x book, little upside remains.

The story

Wells Fargo is a top-four US deposit franchise now operating without the Fed asset cap, letting it grow its balance sheet, trading, and card businesses again. Trailing ROE of about 14% reflects benign credit and expense cuts. Normalized through the cycle, with higher card and CRE losses, returns are closer to the low-to-mid teens. The balance sheet is well capitalized, but heavy buybacks keep book growth modest, and credit sits late-cycle with normalization still ahead.

ROE moves up slightly from 13.3% to 13.5%. Trailing ROE held near 14% and revenue rose to 87B, which supports some lasting benefit from removing the asset cap, but I still haircut for credit normalization rather than extrapolate today's clean loss rates. Book growth stays low because buybacks absorb most retained earnings. Terminal growth stays under the risk-free rate, and beta and failure risk are unchanged.

Value drivers

Return on equity (normalized)13.5%
Book-value growth (Y1)3.0%
Terminal book growth4.0%
Beta1.10
Failure probability1.0%
Cost of equity10.1%

Valuation bridge

PV of excess returns31.90B
PV of terminal excess29.28B
Equity value223.43B
÷ shares → per share$74.43

Projected excess returns on equity

YrBook equityROEExcess returnPV
1164.51B 13.5%5.64B 5.12B
2169.44B 13.3%5.54B 4.57B
3174.72B 13.2%5.44B 4.08B
4180.35B 13.0%5.33B 3.63B
5186.36B 12.9%5.21B 3.22B
6192.78B 12.7%5.08B 2.86B
7199.63B 12.5%4.94B 2.53B
8206.95B 12.4%4.80B 2.23B
9214.77B 12.2%4.64B 1.95B
10223.12B 12.1%4.46B 1.71B

Key risks

  • Credit normalization in commercial real estate (office) and card books pulls ROE back toward 11-12%
  • Falling rates compress net interest income faster than balance-sheet growth replaces it
  • Regulatory or legal relapse (new consent orders, capital rule changes) curbs buybacks or growth

Catalysts

  • Balance-sheet growth after the asset cap lifts net interest income and fee revenue in markets and card
  • Expense efficiency reaching management's high-teens ROTCE target, plus continued large buybacks

History

DatePriceIntrinsicMoSRating
2026-11-17$84.84 $74.43 -12.3% BUY
2026-10-29$83.67 $74.40 -11.1% BUY
2026-10-12$83.55 $72.25 -13.5% BUY
2026-09-23$83.15 $73.64 -11.4% BUY
2026-09-04$89.19 $79.88 -10.4% BUY
2026-08-18$87.54 $76.49 -12.6% BUY
2026-07-30$83.87 $76.93 -8.3% STRONG BUY
2026-07-10$86.91 $73.64 -15.3% BUY
2026-06-23$84.13 $73.99 -12.1% BUY